Hims & Hers Health (HIMS) Shares Outstanding (Diluted Average) (2019 - 2026)

Hims & Hers Health has disclosed Shares Outstanding (Diluted Average) across 8 years of filings, most recently posting $228.4 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $228.4 million, down 7.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $228.4 million (down 7.4% YoY), and the FY2025 annual result was $258.2 million, up 9.05% from the prior year.
• Shares Outstanding (Diluted Average) came in at $228.4 million for Q1 2026 at Hims & Hers Health, down from $258.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $258.2 million in Q4 2025 to a low of $202.7 million in Q1 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $228.4 million (2026), against an average of $225.1 million.
• Across the five-year window, Shares Outstanding (Diluted Average) soared 32.41% in 2022 and decreased 7.4% in 2026, its largest moves.
• Hims & Hers Health's Shares Outstanding (Diluted Average) stood at $204.5 million in 2022, then gained by 2.36% to $209.3 million in 2023, then grew by 13.12% to $236.8 million in 2024, then grew by 9.05% to $258.2 million in 2025, then declined by 11.57% to $228.4 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $228.4 million (Q1 2026), $258.2 million (Q4 2025), and $255.6 million (Q3 2025), per Business Quant data.